Novavax to supply Covax with 1.1B COVID-19 vaccine doses
Novavax announced a memorandum of understanding with Gavi, the Vaccine Alliance, to provide 1.1 billion cumulative doses of its COVID-19 vaccine candidate, NVX-CoV2373, to the Covax facility. The company has also fully enrolled participants in its pivotal phase III clinical trial of NVX-CoV2373. Read More
Thermo Fisher launches new electron microscope
Thermo Fisher Scientific has unveiled its new Helios 5 PXL Wafer DualBeam, a plasma-focused ion beam scanning electron microscope. The microscope can reduce time-to-data from days to hours for inline through-stack metrology and verify high-aspect ratio structures, the firm said. Read More
ImmunoPrecise SARS-CoV-2 antibody cocktail successful in preclinical models
ImmunoPrecise Antibodies has demonstrated that its proprietary TATX-03 PolyTope antibody cocktail against SARS-CoV-2 provides complete clearance of replication-competent virus from the lungs and throat of SARS-CoV-2-infected hamsters. Read More
TriNetX real-world data enable study of COVID-19 vaccine patients
Global health research network TriNetX announced that COVID-19 vaccination data are available in its TriNetX platform and real-world dataset for clinical and observational research. Read More
Immunome discovers spike/nonspike SARS-CoV-2 antibodies
Immunome has isolated potent antibodies that are capable of neutralizing several SARS-CoV-2 variants, including the South African variant (B.1.351), in pseudovirus testing. Read More
Janssen's COVID-19 vaccine submitted to EMA for emergency use
Johnson & Johnson announced that Janssen has submitted a conditional marketing authorization application to the European Medicines Agency (EMA) for its investigational single-dose Janssen COVID-19 vaccine candidate. Read More
Europe purchases more authorized COVID-19 vaccines
A combined 350 million additional doses of COVID-19 vaccines from Pfizer and BioNTech and Moderna will be flooding into Europe in 2021. Read More
Proteomics helps researchers pick the best anti-SARS-CoV-2 nanobodies
A new high-throughput proteomics-based strategy to identify tiny antibody fragments -- called nanobodies -- may provide an efficient and effective method for developing therapeutics against the deadly SARS-CoV-2 virus -- including variants. The findings were published in Cell Systems on February 15. Read More
SK Bioscience to supply Novavax COVID-19 vaccine to millions in Korea
SK Bioscience is set to supply the Korean government with 40 million doses of Novavax's COVID-19 vaccine through a new collaboration and licensing agreement. Read More
AstraZeneca coronavirus vaccine authorized by WHO
The World Health Organization (WHO) has granted an emergency use listing for AstraZeneca's coronavirus vaccine, paving the way for distribution in Africa soon. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter